NCT01462175View on ClinicalTrials.gov

A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Neoplasms
Interventions
DRUG

RO5503781

Trial Locations (8)

3000

Melbourne

33076

Bordeaux

69373

Lyon

L8V 5C2

Hamilton

M5G 2M9

Toronto

H3T 1E2

Montreal

9713 GZ

Groningen

110-744

Seoul

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01462175 - A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia | Biotech Hunter | Biotech Hunter